These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Calvani N; Silvestris F; Dammacco F Ann Ital Med Int; 2001; 16(3):175-8. PubMed ID: 11692907 [TBL] [Abstract][Full Text] [Related]
5. [Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs]. de la Espriella J; Crickx B Ann Dermatol Venereol; 1991; 118(12):948-53. PubMed ID: 1724723 [No Abstract] [Full Text] [Related]
6. Should systemic sclerosis be recognised as an occupational disease in Switzerland? Schmid M; Grolimund Berset D; Krief P; Zyska Cherix A; Danuser B; Rinaldo M Swiss Med Wkly; 2020 Feb; 150():w20193. PubMed ID: 32083706 [TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis secondary to occupational exposure. Owens GR; Medsger TA Am J Med; 1988 Jul; 85(1):114-6. PubMed ID: 3389373 [No Abstract] [Full Text] [Related]
10. Diffused systemic sclerosis due to occupational solvent exposure. Alishiri GH; Saburi A; Bayat N; Saburi E Rheumatol Int; 2013 Jun; 33(6):1649-50. PubMed ID: 22238027 [No Abstract] [Full Text] [Related]
11. Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Yamakage A; Ishikawa H Dermatologica; 1982 Sep; 165(3):186-93. PubMed ID: 6215270 [No Abstract] [Full Text] [Related]
12. Exposure to chemicals and systemic sclerosis. Czirják L; Csiki Z; Nagy Z; Tóth E Ann Rheum Dis; 1995 Jun; 54(6):529. PubMed ID: 7632101 [No Abstract] [Full Text] [Related]
13. Meta-analysis of systemic sclerosis and exposure to solvents. Aryal BK; Khuder SA; Schaub EA Am J Ind Med; 2001 Sep; 40(3):271-4. PubMed ID: 11598973 [TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis and exposure to trichloroethylene. Czirják L; Schlammadinger J; Szegedi G Dermatology; 1993; 186(3):236-7. PubMed ID: 8453156 [No Abstract] [Full Text] [Related]
16. Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry. Muntyanu A; Milan R; Rahme E; Baron M; Netchiporouk E; J Am Acad Dermatol; 2024 Mar; 90(3):605-607. PubMed ID: 37182702 [No Abstract] [Full Text] [Related]
17. Association of occupational exposure with features of systemic sclerosis. Marie I; Menard JF; Duval-Modeste AB; Joly P; Dominique S; Bravard P; Noël D; Gehanno JF; Bubenheim M; Benichou J; Levesque H J Am Acad Dermatol; 2015 Mar; 72(3):456-64. PubMed ID: 25582539 [TBL] [Abstract][Full Text] [Related]
18. Is occupational organic solvent exposure a risk factor for scleroderma? Nietert PJ; Sutherland SE; Silver RM; Pandey JP; Knapp RG; Hoel DG; Dosemeci M Arthritis Rheum; 1998 Jun; 41(6):1111-8. PubMed ID: 9627022 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents. Povey A; Guppy MJ; Wood M; Knight C; Black CM; Silman AJ Arthritis Rheum; 2001 Mar; 44(3):662-5. PubMed ID: 11263781 [TBL] [Abstract][Full Text] [Related]
20. Can scleroderma be induced by anesthetics? Case report. Magnavita N Med Pr; 2016; 67(4):557-60. PubMed ID: 27623836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]